Time To Validate Your Companys Open Payment Submission Data
Mark Linver, Jeffrey Fisher, Juan Tessi
Federal regulators are stepping up scrutiny of the relationships between healthcare providers and pharmaceutical and medical device industries. Potential fines are steep.
New reporting requirements are being phased in. Many industry observers note that regulators are not enforcing their new authority, and wonder when they might begin.
This is not a time for companies to sit back complacently. They should be using this time to test the accuracy of their data and reporting systems, so that when enforcement does increase, as it assuredly will, these companies will know where potential problems are located, and be ready to proactively address them.
To read more content like this, follow @Huron for up-to-date webinar, events, and speaking engagements, and/or subscribe to our weekly newsletter on topical research compliance news.Read More
Subscribe to Huron Insights
Sign Up to get all of the great Huron insights.Newsletter Subscriptions